GIM
ELV icon

Glenmede Investment Management’s Elevance Health ELV Stock Holding History

Glenmede Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$14.5M Sell
44,792
-3,910
-8% -$1.22M 0.07% 249
2025
Q2 		$18.9M Buy
+48,702
New +$19.6M 0.1% 191

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Glenmede Investment Management's ELV Position: Q3 2025 in Review

Glenmede Investment Management reduced its Elevance Health (ELV) stake by 8% in Q3 2025, selling an estimated $1.22M and leaving 44,792 shares worth $14.5M. The position accounts for 0.07% of the portfolio, ranked #249.

Glenmede Investment Management first reported a position in ELV in Q2 2025 and has held it in 2 quarters since. The position peaked at $18.9M in Q2 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Glenmede Investment Management held 44,792 shares of Elevance Health worth $14.5M as of Q3 2025.
  • Glenmede Investment Management sold 3,910 Elevance Health shares in Q3 2025, an estimated $1.22M.
  • Elevance Health made up 0.07% of Glenmede Investment Management's portfolio in Q3 2025, its #249 holding.
  • Glenmede Investment Management first reported a position in Elevance Health in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Elevance Health position peaked at $18.9M in Q2 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.